November 14, 2021
1 min read
Zimmer Biomet Holdings Inc. reported third quarter 2021 net sales of $ 1.924 billion, according to a press release.
Third quarter net sales were down 0.3% from the same period last year and down 0.8% at constant exchange rates. However, sales for the third quarter of 2021 were up 1.7% compared to the third pre-pandemic quarter in 2019.
Zimmer Biomet reported net income of $ 145.6 million, or $ 381.2 million on an adjusted basis, in the third quarter of 2021. The company said diluted earnings per share was $ 0.69 and , when adjusted, diluted earnings per share was $ 1.81.
“Despite persistent challenges and market pressures in the third quarter, we made significant progress in advancing our business priorities and continued to focus on execution to create value and achieve our mission.” Bryan hanson, president, president and chief executive officer of Zimmer Biomet, said in the statement. “Our underlying business remains strong, fueled by our transformation and the launch of innovative new products that can make a difference for our customers and for patients. I continue to be incredibly proud of our team for their dedication, resilience and his performance during this difficult time. “